Product Information
CARVEDILOL ER 20 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $6.7366 per EA under NDC 00115124908. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on May 7, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115124908
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARVEDILOL PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA204717FDA Approved
5/7/2018
TE Code
AB
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL ER 20 MG CAPSULE has been published 130 times since Apr 10, 2024, and over the history we have for it it has risen 15.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7366 per EA |
|---|---|
| All-time high | $6.8402 (May 13, 2026) |
| All-time low | $3.9419 (Nov 20, 2024) |
| 52-week high | $6.8402 |
| 52-week low | $4.4472 |
| Median price | $5.1476 |
| Average price | $5.3223 |
| Largest weekly change | -25.0% (Nov 20, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CARVEDILOL PHOSPHATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CARVEDILOL PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARVEDILOL ER 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL ER 20 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $6.7366 per EA (NDC 00115124908), effective Sep 30, 2026.
How has the price of CARVEDILOL ER 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CARVEDILOL ER 20 MG CAPSULE has risen 15.3%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for CARVEDILOL ER 20 MG CAPSULE?
Since Apr 10, 2024, the NADAC for CARVEDILOL ER 20 MG CAPSULE has ranged from a low of $3.9419 (Nov 20, 2024) to a high of $6.8402 (May 13, 2026), with a median of $5.1476 per EA.
Are there cheaper alternatives to CARVEDILOL ER 20 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of CARVEDILOL ER 20 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CARVEDILOL ER 20 MG CAPSULE?
CARVEDILOL ER 20 MG CAPSULE (NDC 00115124908) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.